Digital Agenda for Europe
A Europe 2020 Initiative

Biochemical signature predicts progression to Alzheimer's disease

Article
A study led by Research Professor Matej Orešič from VTT Technical Research Centre of Finland (participating in EU funded PredictAD project) suggests that Alzheimer’s disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway. This indicator can be analysed as a simple biochemical assay from a serum sample months or even years before the first symptoms of the disease occur. In a healthcare setting, application of such an assay could therefore complement the neurocognitive assessment by the medical doctor and could be applied to identify the at-risk patients in need of further comprehensive follow-up.
Share this